Enhanced recovery after surgery (ERAS) pathway for primary hip and knee arthroplasty: study protocol for a randomized controlled trial

Jingyi Li, Haibei Zhu, Ren Liao, Jingyi Li, Haibei Zhu, Ren Liao

Abstract

Background: With the substantially growing trend of the aging populations in China and the rest of the world, the number of total hip and total knee arthroplasty (THA and TKA) cases are increasing dramatically. It is important to develop practical strategies to improve the quality of healthcare and better outcome for patients undergoing THA and TKA. Enhanced recovery after surgery (ERAS) pathways have been reported to promote earlier recovery and be beneficial for patients. We propose the hypothesis that the ERAS pathway could reduce the length of stay (LOS) in hospital for patients undergoing primary THA or TKA.

Methods/design: This trial is a prospective, open-labelled, multi-centered, randomized controlled trial that will test the superiority of the ERAS pathway in term of LOS in hospital for the patients undergoing primary THA or TKA compared to current non-ERAS clinical practice. A total of 640 patients undergoing primary THA or TKA will be randomly allocated to either ERAS pathway (ERAS group) or conventional care according to individual participating center (non-ERAS group). The primary outcome is the total LOS in hospital; the secondary outcomes include postoperative LOS, all-cause mortality by 30 days after operation, in-hospital complications, early mobilization, postoperative pain control, total in-hospital cost, and readmission rate by 30 days after discharge from the hospital.

Discussion: This trial is designed to evaluate the superiority of the ERAS pathway to conventional non-ERAS clinical practice in reducing the LOS. The results may provide new insight into the clinical applications of the ERAS pathway for THA and TKA.

Trial registration: National Institutes of Health Clinical Trials Registry, NCT03517098 . Registered on 4 May 2018.

Keywords: Enhanced recovery after surgery; Randomized controlled trial; Total hip arthroplasty; Total knee arthroplasty.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart for participant eligibility, interventions, assessments, and follow-up
Fig. 2
Fig. 2
Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) figure (numbers beside t represent days)

References

    1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–785.
    1. Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth. 1997;78:606–617. doi: 10.1093/bja/78.5.606.
    1. Geltzeiler CB, Rotramel A, Wilson C, Deng L, Whiteford MH, Frankhouse J. Prospective study of colorectal enhanced recovery after surgery in a community hospital. JAMA Surg. 2014;149:955–956. doi: 10.1001/jamasurg.2014.675.
    1. Li S, Zhou K, Che G, Yang M, Su J, Shen C, Yu P. Enhanced recovery programs in lung cancer surgery: systematic review and meta-analysis of randomized controlled trials. Cancer Manag Res. 2017;9:657–670. doi: 10.2147/CMAR.S150500.
    1. Wainwright TW, Immins T, Middleton RG. Enhanced recovery after surgery (ERAS) and its applicability for major spine surgery. Best Pract Res Clin Anaesthesiol. 2016;30(1):91–102. doi: 10.1016/j.bpa.2015.11.001.
    1. Soffin EM, YaDeau JT. Enhanced recovery after surgery for primary hip and knee arthroplasty: a review of the evidence. Br J Anaesth. 2016;117(suppl 3):iii62–iii72. doi: 10.1093/bja/aew362.
    1. Hollman F, Wolterbeek N, Veen R. Risk Factors for Postoperative Urinary Retention in Men Undergoing Total Hip Arthroplasty. Orthopedics. 2015;38(6):e507–e511. doi: 10.3928/01477447-20150603-59.
    1. Berninger MT, Friederichs J, Leidinger W, et al. Effect of local infiltration analgesia, peripheral nerve blocks, general and spinal anesthesia on early functional recovery and pain control in total knee arthroplasty. BMC Musculoskelet Disord. 2018;19(1):232. doi: 10.1186/s12891-018-2154-z.
    1. Mandel JE. Considerations for the use of short-acting opioids in general anesthesia. J Clin Anesth. 2014;26(1 Suppl):S1–S7. doi: 10.1016/j.jclinane.2013.11.003.
    1. Chow S, Shao J, Wang H. Sample Size Calculations in Clinical Research (2nd edn). Boca Raton: Chapman & Hall/CRC Biostatistics Series (Chapman and Hall/CRC); 2008. p. 61.
    1. Christelis N, Wallace S, Sage CE, et al. An enhanced recovery after surgery program for hip and knee arthroplasty. Med J Aust. 2015;202:363–368. doi: 10.5694/mja14.00601.
    1. Wijk L, Franzen K, Ljungqvist O, Nilsson K. Implementing a structured Enhanced Recovery After Surgery (ERAS) protocol reduces length of stay after abdominal hysterectomy. Acta Obstet Gynecol Scand. 2014;93(8):749–756. doi: 10.1111/aogs.12423.
    1. Pędziwiatr M, Kisialeuski M, Wierdak M, Stanek M, Natkaniec M, Matłok M, Major P, Małczak P, Budzyński A. Early implementation of Enhanced Recovery After Surgery (ERAS®) protocol - Compliance improves outcomes: A prospective cohort study. Int J Surg. 2015;21:75–81. doi: 10.1016/j.ijsu.2015.06.087.
    1. Khan S, Gatt M, MacFie J. Enhanced recovery programmes and colorectal surgery: does the laparoscope confer additional advantages? Color Dis. 2009;11(9):902–908. doi: 10.1111/j.1463-1318.2009.01781.x.
    1. Ljungqvist O, Scott M, Fearon KC. Enhanced Recovery After Surgery: A Review. JAMA Surg. 2017;152(3):292–298. doi: 10.1001/jamasurg.2016.4952.
    1. Coolsen MM, van Dam RM, van der Wilt AA, Slim K, Lassen K, Dejong CH. Systematic review and meta-analysis of enhanced recovery after pancreatic surgery with particular emphasis on pancreaticoduodenectomies. World J Surg. 2013;37(8):1909–1918. doi: 10.1007/s00268-013-2044-3.
    1. Liu F, Wang W, Wang C, Peng X. Enhanced recovery after surgery (ERAS) programs for esophagectomy protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2018;97(8):e0016. doi: 10.1097/MD.0000000000010016.
    1. Tong D, Chung F, Wong D. Predictive factors in global and anesthesia satisfaction in ambulatory surgical patients. Anesthesiology. 1997;87(4):856–864. doi: 10.1097/00000542-199710000-00020.
    1. Homburger JA, Meiler SE. Anesthesia drugs, immunity, and long-term outcome. Curr Opin Anaesthesiol. 2006;19(4):423–428. doi: 10.1097/01.aco.0000236143.61593.14.
    1. Dürsteler C, Mases A, Puig MM. Universal PONV prophylaxis in general anesthesia: should we consider its immediate implementation? Anesth Analg. 2008;106(6):1922. doi: 10.1213/ane.0b013e318172c6f1.
    1. Newman S, Stygall J, Hirani S, Shaefi S, Maze M. Postoperative cognitive dysfunction after noncardiac surgery: a systematic review. Anesthesiology. 2007;106(3):572–590. doi: 10.1097/00000542-200703000-00023.
    1. Song D, White PF. Remifentanil as an adjuvant during desflurane anesthesia facilitates early recovery after ambulatory surgery. J Clin Anesth. 1999;11:364–367. doi: 10.1016/S0952-8180(99)00061-6.
    1. Shayne M, Culakova E, Poniewierski MS, Dale DC, Crawford J, Wogu AF, Lyman GH. Risk factors for in-hospital mortality and prolonged length of stay in older patients with solid tumor malignancies. J Geriatr Oncol. 2013;4(4):310–318. doi: 10.1016/j.jgo.2013.05.005.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する